Author: Teresa McNulty
-
First-in-class clascoterone opens a new door for acne care
Clascoterone 1% cream (Winlevi, Cassiopea) is a first-in-class topical androgen receptor Its efficacy and safety for treating moderate-to-severe acne and reducing noninflammatory and inflammatory lesions was demonstrated in 2 pivotal trials including 1440 patients ages 9 years and older Data from an open-label extension study provided evidence of safety during longer-term use Studies of clascoterone… Read more
-
Therapeutic approaches you’ve never heard of but will use next week
Dermatologist Matthew J. Zirwas, M.D., says it would be shocking if a day went by when he didn’t use one of these therapeutic approaches in practice. After all, each meets his criteria for being cheap, safe and making sense. The following treatments are so cheap that they don’t need prior authorizations and patients can afford… Read more